Skip to main content

Table 3 Treatment of recurrence for patients after liver metastases resection

From: Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis

CharacteristicsBefore PSM (n = 240)After PSM (n = 99)
Right-sided group (n = 54)Left-sided group (n = 186)P valueRight-sided group (n = 53)Left-sided group (n = 46)P value
Resection alone, n (%)3 (5.6)20 (10.7)0.3063 (5.7)9 (19.6)0.134
Ablation alone, n (%)11 (20.4)29 (15.6)0.40711 (20.8)7 (15.2)0.476
Chemotherapy alone, n (%)27 (50.0)70 (37.7)0.10318 (34.0)17 (37.0)0.756
Resection + chemotherapy, n (%)3 (5.6)9 (4.8)0.7353 (5.7)2 (4.3)1.000
Resection + radiotherapy, n (%)1 (1.8)3 (1.6)0.9051 (1.8)0 (0.0)NA
Ablation + chemotherapy, n (%)3 (5.6)25 (13.4)0.1493 (5.7)2 (4.3)1.000
Ablation + radiotherapy, n (%)0 (0.0)2 (1.1)NA0 (0.0)0 (0.0)NA
Radio + chemotherapy, n (%)0 (0.0)2 (1.1)NA0 (0.0)0 (0.0)NA
Supportive care, n (%)6 (11.1)26 (14.0)0.58514 (26.4)9 (19.6)0.421
  1. PSM propensity score matching